Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

The updated recommendations are pending final approval by the director of the CDC and the Department of Health and Human Services.

The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...

A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...

Official Cause Of Death Released For 14-Year-Old Son Of Ex-Yankees Star The official cause of death has been released for the teenage son of a former Major League Baseball star who died while on a ...

Vaxcyte’s stock has dropped around 45% despite a Phase II trial of its invasive pneumococcal disease (IPD) vaccine meeting all endpoints. The Nasdaq-listed company saw its stock price, drop from a ...

Given the uncertain regulatory environment, I am downgrading Vaxcyte's stock to "Hold" until there's more clarity on the FDA's stance on PCV vaccines. Phase 2 dose-finding study evaluating the ...

No serious adverse events were considered to be related to the study vaccines. Post-dose 3, the VAX-24 Mid dose met target precedent Phase 2 non-inferiority (NI) criteria on relative ...

meningitidis military personnel who are at increased risk of meningococcal disease close contacts of a case of IMD and for individuals at risk in an outbreak setting if the disease is caused by a ...

These included: Capvaxive is Merck’s FDA-approved 21-valent pneumococcal conjugate vaccine indicated for active immunization for the prevention of invasive disease and pneumonia in adults 18 years of ...

vaccine, four doses of the pneumococcal conjugate vaccine, and five doses of the DTaP (diphtheria, tetanus and pertussis) vaccine. Nagappan said it’s important to get children to get their ...